Impact of OATP1B1, MDR1, and CYP3A4 expression in liver and intestine on interpatient pharmacokinetic variability of atorvastatin in obese subjects
Ulvestad, M, Skottheim, I B, Jakobsen, G S, Bremer, S, Molden, E, Asberg, A, Hjelmesæth, J, Andersson, T B, Sandbu, R, Christensen, H
Published in Clinical pharmacology and therapeutics (01.03.2013)
Published in Clinical pharmacology and therapeutics (01.03.2013)
Get more information
Journal Article
Impact of age, gender and CYP2C9/2C19 genotypes on dose-adjusted steady-state serum concentrations of valproic acid—a large-scale study based on naturalistic therapeutic drug monitoring data
Smith, R. L., Haslemo, T., Refsum, H., Molden, E.
Published in European journal of clinical pharmacology (01.09.2016)
Published in European journal of clinical pharmacology (01.09.2016)
Get full text
Journal Article
Influence of FMO1 and 3 polymorphisms on serum olanzapine and its N-oxide metabolite in psychiatric patients
Söderberg, M M, Haslemo, T, Molden, E, Dahl, M-L
Published in The pharmacogenomics journal (01.12.2013)
Published in The pharmacogenomics journal (01.12.2013)
Get full text
Journal Article
UGT1A43 encodes significantly increased glucuronidation of olanzapine in patients on maintenance treatment and in recombinant systems
Haslemo, T, Loryan, I, Ueda, N, Mannheimer, B, Bertilsson, L, Ingelman-Sundberg, M, Molden, E, Eliasson, E
Published in Clinical pharmacology and therapeutics (01.08.2012)
Published in Clinical pharmacology and therapeutics (01.08.2012)
Get more information
Journal Article
The complexity of active metabolites in therapeutic drug monitoring of psychotropic drugs
Hendset, M, Haslemo, T, Rudberg, I, Refsum, H, Molden, E
Published in Pharmacopsychiatry (01.07.2006)
Published in Pharmacopsychiatry (01.07.2006)
Get more information
Journal Article
4β‐Hydroxycholesterol Level in Patients With Rheumatoid Arthritis Before vs. After Initiation of bDMARDs and Correlation With Inflammatory State
Wollmann, BM, Syversen, SW, Lie, E, Gjestad, C, Mehus, LL, Olsen, IC, Molden, E
Published in Clinical and translational science (01.01.2017)
Published in Clinical and translational science (01.01.2017)
Get full text
Journal Article
Identification of a Novel CYP2C19-Mediated Metabolic Pathway of S-Citalopram in Vitro
RUDBERG, I, REUBSAET, J. L. E, HERMANN, M, REFSUM, H, MOLDEN, E
Published in Drug metabolism and disposition (01.12.2009)
Published in Drug metabolism and disposition (01.12.2009)
Get full text
Journal Article
Identification of epoxybergamottin as a CYP3A4 inhibitor in grapefruit peel
WANGENSTEEN, H, MOLDEN, E, CHRISTENSEN, H, MALTERUD, K. E
Published in European journal of clinical pharmacology (01.02.2003)
Published in European journal of clinical pharmacology (01.02.2003)
Get full text
Journal Article
Pharmacogenomics in treatment of depression and psychosis: an update
Jukic, Marin, Milosavljević, Filip, Molden, Espen, Ingelman-Sundberg, Magnus
Published in Trends in pharmacological sciences (Regular ed.) (01.12.2022)
Published in Trends in pharmacological sciences (Regular ed.) (01.12.2022)
Get full text
Journal Article
Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure: A Systematic Review and Meta-analysis
Milosavljevic, Filip, Bukvic, Nikola, Pavlovic, Zorana, Miljevic, Cedo, Pešic, Vesna, Molden, Espen, Ingelman-Sundberg, Magnus, Leucht, Stefan, Jukic, Marin M
Published in JAMA psychiatry (Chicago, Ill.) (01.03.2021)
Published in JAMA psychiatry (Chicago, Ill.) (01.03.2021)
Get more information
Journal Article